7.5 dose tirzepatide Zepbound mg/0.5 mL injection (single-dose pen) Images Tirzepatide dosage chart for weight

While most people tolerate them well, its helpful to know what side effects to expect, especially in the first few weeks of treatment: nausea vomiting diarrhea constipation headaches fatigue These symptoms are well-documented across clinical trials and often appear during the dose escalation phase

Zepbound was approved by the FDA in November 2023 for chronic weight management in adults with obesity as well as those who are overweight and have at least one weight-related condition like high blood pressure or high cholesterol

Always, the key is to listen to your body

Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V et al